Company Filing History:
Years Active: 2003-2005
Title: Inventor Spotlight: Jeffrey D. Klinger
Introduction
Jeffrey D. Klinger, an innovative inventor based in Sudbury, MA, has made significant contributions to the fields of antimicrobial agents and treatment methodologies for oral mucositis. With a total of two patents to his name, Klinger demonstrates a commitment to advancing healthcare through groundbreaking research and development.
Latest Patents
Klinger’s latest patents highlight his dedication to improving medical treatments. One of his notable inventions is related to ionene polymers, which possess antimicrobial activity. These ionene polymers are designed with a substantial proportion of quaternized nitrogens integrated into the main polymeric chain. This innovation opens avenues for treating microbial infections in mammals by administering effective antimicrobial compositions.
Additionally, Klinger has developed bismuth compounds critical for treating and preventing oral mucositis. His research reveals that bismuth-containing compounds, including a range of bismuth salts and complexes, are effective in alleviating this condition, benefiting countless patients.
Career Highlights
Throughout his career, Jeffrey D. Klinger has worked with reputable companies such as Genzyme Corporation and Geltex Pharmaceuticals, Inc. His professional journey is marked by his strides in pharmaceutical sciences and his unwavering dedication to health innovations.
Collaborations
Klinger has collaborated with esteemed professionals in his field, including Richard Fitzpatrick and Keith K. Shackett. Such partnerships enrich his research endeavors and contribute to the successful development of his inventions, demonstrating the importance of collaboration in scientific progress.
Conclusion
Jeffrey D. Klinger stands out as a noteworthy inventor whose work continues to impact the medical industry. With his innovative patents and collaboration with other professionals, he exemplifies the essence of dedication to improving healthcare through scientific advancements. As research in antimicrobial agents and treatment solutions evolves, Klinger's contributions remain invaluable.